This article assesses the contribution of computer-aided molecular design (CAMD) to the field of drug discovery. Several examples of ligand- and structure-based drug design are used to demonstrate the role of CAMD in the discovery of marketed drug compounds. Although CAMD is now an integral part of many drug discovery projects, there are significant challenges still facing its practitioners, particularly the prediction of binding affinity.
No takes yet. Share an insight, caveat, or question.
David E. Clark (2006) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: